Second Generation of Zafirlukast Derivatives with Improved Activity Against the Oral Pathogen

Overview

Journal ACS Med Chem Lett

Publisher American Chemical Society

Specialty Chemistry

Date 2020 Oct 16

PMID 33062172

Citations 3

Authors

Kaitlind C Howard

Octavio A Gonzalez

Sylvie Garneau-Tsodikova

Affiliations

Soon will be listed here.

Abstract

is a Gram-negative anaerobic pathogen that can trigger oral dysbiosis as an early event in the pathogenesis of periodontal disease. The FDA-approved drug zafirlukast (ZAF) was recently shown to display antibacterial activity against . Here, 15 novel ZAF derivatives were synthesized and evaluated for their antibacterial activity against and for their cytotoxic effects. Most derivatives displayed superior antibacterial activity against compared to ZAF and its first generation derivatives along with little to no growth inhibition of other oral bacterial species. The most active compounds displayed bactericidal activity against and less cytotoxicity than ZAF. The superior and selective antibacterial activity of ZAF derivatives against along with an increased safety profile compared to ZAF suggest these new compounds, especially and , show promise as antibacterials for future studies aimed to test their potential for preventing/treating -induced periodontal disease.

Citing Articles

The Link between Periodontal Disease and Asthma: How Do These Two Diseases Affect Each Other?.

Tamiya H, Abe M, Nagase T, Mitani A J Clin Med. 2023; 12(21).

PMID: 37959214 PMC: 10650117. DOI: 10.3390/jcm12216747.

: where do we stand in our battle against this oral pathogen?.

Howard K, Gonzalez O, Garneau-Tsodikova S RSC Med Chem. 2021; 12(5):666-704.

PMID: 34124669 PMC: 8152699. DOI: 10.1039/d0md00424c.

Presenting a Special Issue on "Medicinal Chemistry: From Targets to Therapies".

Maryanoff B, Wipf P ACS Med Chem Lett. 2020; 11(10):1780-1782.

PMID: 33062151 PMC: 7549098. DOI: 10.1021/acsmedchemlett.0c00508.

References

Ashburn T, Thor K . Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004; 3(8):673-83. DOI: 10.1038/nrd1468. View

Kim J, Amar S . Periodontal disease and systemic conditions: a bidirectional relationship. Odontology. 2006; 94(1):10-21. PMC: 2443711. DOI: 10.1007/s10266-006-0060-6. View

Dickson M, Hahn W, Ino Y, Ronfard V, Wu J, Weinberg R . Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol. 2000; 20(4):1436-47. PMC: 85304. DOI: 10.1128/MCB.20.4.1436-1447.2000. View

Mombelli A, AlMaghlouth A, Cionca N, Courvoisier D, Giannopoulou C . Differential benefits of amoxicillin-metronidazole in different phases of periodontal therapy in a randomized controlled crossover clinical trial. J Periodontol. 2014; 86(3):367-75. DOI: 10.1902/jop.2014.140478. View

Diniz C, Farias L, Carvalho M, Rocha E, Jeffrey Smith C . Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutant. J Antimicrob Chemother. 2004; 54(1):100-8. DOI: 10.1093/jac/dkh256. View

Sum J, ORourke V . Factors affecting periodontal disease referral and the adherence to guidelines among general dentists. Aust Dent J. 2018; 63(4):394-401. DOI: 10.1111/adj.12641. View

Kelloway J . Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma. Ann Pharmacother. 1997; 31(9):1012-21. DOI: 10.1177/106002809703100912. View

Dominy S, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A . in Alzheimer's disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 2019; 5(1):eaau3333. PMC: 6357742. DOI: 10.1126/sciadv.aau3333. View

Moreno Villagrana A, Gomez Clavel J . Antimicrobial or subantimicrobial antibiotic therapy as an adjunct to the nonsurgical periodontal treatment: a meta-analysis. ISRN Dent. 2012; 2012:581207. PMC: 3485543. DOI: 10.5402/2012/581207. View

10.

Mestnik M, Feres M, Figueiredo L, Soares G, Teles R, Fermiano D . The effects of adjunctive metronidazole plus amoxicillin in the treatment of generalized aggressive periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. J Clin Periodontol. 2012; 39(10):955-61. DOI: 10.1111/j.1600-051X.2012.01932.x. View

11.

Chong C, Sullivan Jr D . New uses for old drugs. Nature. 2007; 448(7154):645-6. DOI: 10.1038/448645a. View

12.

Eke P, Dye B, Wei L, Thornton-Evans G, Genco R . Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 2012; 91(10):914-20. DOI: 10.1177/0022034512457373. View

13.

Pinault L, Han J, Kang C, Franco J, Ronning D . Zafirlukast inhibits complexation of Lsr2 with DNA and growth of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2013; 57(5):2134-40. PMC: 3632936. DOI: 10.1128/AAC.02407-12. View

14.

Chandrika N, Fosso M, Alimova Y, May A, Gonzalez O, Garneau-Tsodikova S . Novel zafirlukast derivatives exhibit selective antibacterial activity against . Medchemcomm. 2019; 10(6):926-933. PMC: 6596388. DOI: 10.1039/c9md00074g. View

15.

Martinez A, Espinosa B, Adamek R, Thomas B, Chau J, Gonzalez E . Breathing new life into West Nile virus therapeutics; discovery and study of zafirlukast as an NS2B-NS3 protease inhibitor. Eur J Med Chem. 2018; 157:1202-1213. DOI: 10.1016/j.ejmech.2018.08.077. View

16.

Mombelli A, Cionca N, AlMaghlouth A . Does adjunctive antimicrobial therapy reduce the perceived need for periodontal surgery?. Periodontol 2000. 2010; 55(1):205-16. DOI: 10.1111/j.1600-0757.2010.00356.x. View

17.

Mikuls T, Payne J, Yu F, Thiele G, Reynolds R, Cannon G . Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol. 2014; 66(5):1090-100. PMC: 4115329. DOI: 10.1002/art.38348. View

18.

Shaikh S, Fatima J, Shakil S, Danish Rizvi S, Kamal M . Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi J Biol Sci. 2015; 22(1):90-101. PMC: 4281622. DOI: 10.1016/j.sjbs.2014.08.002. View

19.

Fernandez-Solari J, Barrionuevo P, Mastronardi C . Periodontal Disease and Its Systemic Associated Diseases. Mediators Inflamm. 2015; 2015:153074. PMC: 4539498. DOI: 10.1155/2015/153074. View

20.

Hegde R, Awan K . Effects of periodontal disease on systemic health. Dis Mon. 2018; 65(6):185-192. DOI: 10.1016/j.disamonth.2018.09.011. View